Rungby, Jørgen
Bispebjerg Hospital · Copenhagen University Hospital · Steno Diabetes Center Copenhagen
12 papers on CoChatORCID 0000-0002-5207-623X
Most cited papers
- Verified
In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 480
- Verified
Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables.
Miskowiak, K., Johnsen, S., Sattler, S., Nielsen, S., Kunalan, K., Rungby, J., Lapperre, T., & Porsberg, C. (2021) · European Neuropsychopharmacology
Long-Term Effects of COVID-19Intensive Care Unit Cognitive Disorders
Cited by 365
- Verified
Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case–control study
Wium-Andersen, I. K., Osler, M., Jørgensen, M. B., Rungby, J., & Wium-Andersen, M. K. (2019) · European Journal of Endocrinology
Diabetes Treatment and ManagementDementia and Cognitive Impairment Research
Cited by 182
- Verified
Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
Gejl, M., Brock, B., Egefjord, L., Vang, K., Rungby, J., & Gjedde, A. (2017) · Scientific Reports
Alzheimer's disease research and treatmentsBarrier Structure and Function Studies
Cited by 163
- Verified
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease
Nielsen, R. B., Egefjord, L., Angleys, H., Mouridsen, K., Gejl, M., Møller, A., Brock, B., Brændgaard, H., Gottrup, H., Rungby, J., et al. (2017) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 119
- Verified
Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series study
Wium‐Andersen, I. K., Wium‐Andersen, M. K., Fink‐Jensen, A., Rungby, J., Jørgensen, M. B., & Osler, M. (2022) · Basic & Clinical Pharmacology & Toxicology
Diabetes Treatment and ManagementSubstance Abuse Treatment and Outcomes
Cited by 93
- Verified
Early‐onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes—Results from the DD2 study
Bo, A., Thomsen, R. W., Nielsen, J. S., Nicolaisen, S. K., Beck‐Nielsen, H., Rungby, J., Sørensen, H. T., Hansen, T. K., Søndergaard, J., Friborg, S., et al. (2018) · Diabetes/Metabolism Research and Reviews
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 62
- Verified
Neuroprotective Mechanisms of Glucagon‐like Peptide‐1‐based Therapies in Ischaemic Stroke: A Systematic Review based on Pre‐Clinical Studies
Marlet, I. R., Ölmestig, J. N. E., Vilsbøll, T., Rungby, J., & Kruuse, C. (2018) · Basic & Clinical Pharmacology & Toxicology
Neuroprotection in Cerebral IschemiaAcute Ischemic Stroke Management
Cited by 61
- Verified
Fractures in Patients with Primary Idiopathic Hypothyroidism
Vestergaard, P., Weeke, J., Hoeck, H. C., Nielsen, H. K., Rungby, J., Rejnmark, L., Laurberg, P., & Mosekilde, L. (2000) · Thyroid®
Thyroid Disorders and TreatmentsBone health and osteoporosis research
Cited by 57
- Verified
Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxine treatment
Gjedde, S., Vestergaard, E. T., Gormsen, L. C., Riis, A. L. D., Rungby, J., Møller, N., Weeke, J., & Jørgensen, J. O. L. (2008) · The Journal of Clinical Endocrinology & Metabolism
Regulation of Appetite and ObesityThyroid Disorders and Treatments
Cited by 44
- Verified
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats
DellaValle, B., Brix, G. S., Brock, B., Gejl, M., Landau, A. M., Møller, A., Rungby, J., & Larsen, A. (2016) · Frontiers in Pharmacology
Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders
Cited by 39
- Verified
Glucagonlike peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors in ischemic strokes with diabetes 2.
Hastrup, S., Hedegaard, J. N., Andersen, G., Rungby, J., & Johnsen, S. P. (2024) · European Journal of Neurology
Diabetes Treatment and ManagementAcute Ischemic Stroke Management
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free